Why the study?
Does intravenous isoproterenol and epinephrine prevent ventricular tachycardia and fibrillation in patients with Stokes-Adams attacks?
Does intravenous isoproterenol and epinephrine prevent ventricular tachycardia and fibrillation in patients with Stokes-Adams attacks?
Intravenous isoproterenol and epinephrine are effective for the prompt, short-term prevention of ventricular tachycardia and fibrillation in patients with Stokes-Adams attacks, though long-term management requires internal pacemakers.
Answers are grounded in this paper and cite their sources.
May support short-term isoproterenol/epinephrine use in Stokes-Adams attacks; leaves open randomized comparisons with pacing.
Isoproterenol and epinephrine were given intravenously in dilute solutions to nine patients with Stokes-Adams attacks due to ventricular tachycardia and fibrillation. The drugs produced ventricular acceleration and thereby controlled the attacks. This technic proved useful for prompt, short-term prevention of seizures; for the long term, direct electric stimulation with internal pacemakers was required.
No takes yet. Share an insight, caveat, or question.
Linenthal et al. (1963) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: